v3.23.1
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenue    
Total revenue $ 337,244 $ 263,258
Operating expenses    
Cost of services, excluding depreciation and amortization 289,397 220,730
General and administrative expenses 21,182 11,943
Depreciation and amortization 4,292 4,374
Total expenses 314,871 237,047
Income from operations 22,373 26,211
Other (expense) income    
Income from equity method investments 2,484 1,433
Interest expense (3,269) (1,073)
Interest income 3,009 46
Unrealized loss on investments (6,392) (8,962)
Other income 1,204 613
Total other expense, net (2,964) (7,943)
Income before provision for income taxes 19,409 18,268
Provision for income taxes 5,102 6,195
Net income 14,307 12,073
Net loss attributable to non-controlling interest (315) (2,191)
Net income attributable to Apollo Medical Holdings, Inc. $ 14,622 $ 14,264
Earnings per share – basic (in dollars per share) $ 0.31 $ 0.32
Earnings per share – diluted (in dollars per share) $ 0.31 $ 0.31
Capitation, net    
Revenue    
Total revenue $ 300,204 $ 222,060
Risk pool settlements and incentives    
Revenue    
Total revenue 13,462 18,075
Management fee income    
Revenue    
Total revenue 9,896 10,473
Fee-for-service, net    
Revenue    
Total revenue 12,062 11,095
Other income    
Revenue    
Total revenue $ 1,620 $ 1,555

Source